Also trades as: BIAF (NASDAQ) · $vol 13M
BIAFW NASDAQ
bioAffinity Technologies, Inc.
1W: +14.0%
1M: +106.6%
3M: +111.6%
YTD: +28.7%
1Y: +175.2%
$0.33
+0.01 (+3.28%)
Weekly Expected Move ±72.8%
$-0
$0
$0
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$11.8M
52W Range0.0501-0.98
Volume1,044
Avg Volume1,207
Beta-1.05
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMaria Zannes
Employees57
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2026-03-06
Websitebioaffinitytech.com
3300 Nacogdoches Road
San Antonio, TX 78217
US
San Antonio, TX 78217
US
+1 210 698 5334
About bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Latest News
WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering
bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 1.1% – Time to Sell?
bioAffinity Technologies, Inc. (NASDAQ:BIAF) Short Interest Up 142.0% in March
bioAffinity Technologies (NASDAQ:BIAFW) Shares Down 15.3% – Time to Sell?
bioAffinity Technologies, Inc. (NASDAQ:BIAF) Short Interest Up 164.9% in February
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Rios Roberto | 0 | — | 2025-08-12 | |
| Oppenheimer John J. | 0 | — | 2025-08-12 | |
| Reveles Xavier Trini | A-Award | 21,604 | — | 2025-01-10 |
| GIRGENTI STEVEN | A-Award | 14,814 | — | 2025-01-10 |
| Zannes Maria | A-Award | 37,037 | — | 2025-01-10 |